JAGUAR HEALTH, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
JAGUAR HEALTH, INC. (JAGX) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $109.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-19
- JAGUAR HEALTH, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $109.00K.
- JAGUAR HEALTH, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- JAGUAR HEALTH, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- JAGUAR HEALTH, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00.
- JAGUAR HEALTH, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $341.00K, a 54.30% increase from fiscal 2024.
- JAGUAR HEALTH, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $221.00K, a 636.67% increase from fiscal 2023.
- JAGUAR HEALTH, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $30.00K, a 91.78% decline from fiscal 2022.
- JAGUAR HEALTH, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $365.00K, a 66.42% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $109.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $109.00K 10-Q · filed 2026-08-19 | $109.00K derived: sum of 3 quarters · filed 2026-08-19 | $109.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-20 | $0.00 derived: sum of 2 quarters · filed 2026-05-20 | $0.00 derived: sum of 3 quarters · filed 2026-05-20 | $0.00 derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $0.00 derived: sum of 2 quarters · filed 2026-04-07 | $0.00 derived: sum of 3 quarters · filed 2026-08-19 | $341.00K 10-K · filed 2026-04-07 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-19 | $341.00K 10-Q · filed 2025-11-14 | $343.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $341.00K 10-Q · filed 2026-08-19 | $343.00K derived: sum of 3 quarters · filed 2026-08-19 | $343.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $341.00K 10-Q · filed 2026-05-20 | $343.00K derived: sum of 2 quarters · filed 2026-05-20 | $343.00K derived: sum of 3 quarters · filed 2026-05-20 | $341.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $2.00K derived: sum of 2 quarters · filed 2026-04-07 | $0.00 derived: sum of 3 quarters · filed 2026-04-07 | $221.00K 10-K · filed 2026-04-07 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.00K derived: sum of 2 quarters · filed 2025-11-14 | $219.00K 10-Q · filed 2025-11-14 | $219.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $219.00K 10-Q · filed 2025-08-14 | $219.00K derived: sum of 3 quarters · filed 2025-08-14 | $219.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $221.00K 10-Q · filed 2025-05-15 | $221.00K derived: sum of 2 quarters · filed 2025-05-15 | $221.00K derived: sum of 3 quarters · filed 2025-05-15 | $221.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $30.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $30.00K 10-Q · filed 2024-11-13 | $172.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $30.00K 10-Q · filed 2024-08-13 | $172.00K derived: sum of 3 quarters · filed 2024-08-13 | $172.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $30.00K 10-Q · filed 2024-05-14 | $172.00K derived: sum of 2 quarters · filed 2024-05-14 | $172.00K derived: sum of 3 quarters · filed 2024-05-14 | $305.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $142.00K derived: sum of 2 quarters · filed 2024-04-01 | $275.00K derived: sum of 3 quarters · filed 2024-04-01 | $365.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $133.00K derived: sum of 2 quarters · filed 2023-11-14 | $223.00K 10-Q · filed 2023-11-14 | $223.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $223.00K 10-Q · filed 2023-08-14 | $223.00K derived: sum of 3 quarters · filed 2023-08-14 | $223.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $90.00K 10-Q · filed 2023-05-15 | $90.00K derived: sum of 2 quarters · filed 2023-05-15 | $90.00K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $0.00 derived: sum of 2 quarters · filed 2023-03-24 | $1.09M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-17 | $1.09M 10-Q · filed 2021-11-17 | ||
| 2021-06-30 | $1.09M 10-Q · filed 2021-08-13 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |